Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
WVE
Wave Life Sciences
$7.15
Login to see Wave Life Sciences (WVE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Chart
$7.48 (-4.41%)
$7.83 (-8.68%)
$6.29 (+13.67%)
$15.31 (-53.30%)
WVE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
WVE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
WVE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
WVE Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWVE Earnings
The TTM reflects 12-month period, providing review of WVE financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is WVE current stock price?
What are WVE stock strengths?
What risks are associated with WVE stock?
When is WVE next earnings report?
What is WVE market cap and volume?
What is WVE's current Stock IQ?
Should I buy WVE stock right now?
Is WVE a Strong Buy right now?
What does a 'Strong Buy' rating mean for WVE?
What does a 'Strong Sell' rating mean for WVE?
What factors influence WVE's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
WVE
Wave Life Sciences
Current Price
$7.15
Stock Insights
Strengths
Earnings are forecast to grow
Login to unlock Wave Life Sciences (WVE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$7.48 (-4.41%)
$7.83 (-8.68%)
$6.29 (+13.67%)
$15.31 (-53.30%)
WVE Analysts Opinion
WVE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
WVE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
WVE Street view is extremely bullish and have positive views on the near-term outlook
WVE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayWVE Earnings
The TTM data reflects the most recent 12-month period, providing overview of WVE financial performance.
WVE Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
WVE Latest Analysis
Invivyd Appoints Paul B. Bolno M.D. to Its Board of Directors. NEW HAVEN Conn. Sept. 24 2025 (GLOBE NEWSWIRE) -- Invivyd Inc. (NASDAQ:) today announced the appointment of Paul B. Bolno M.D. to its Board of Directors and as a member of the Compensation Committee. Dr. Bolno is the President and CEO of Wave Life Sciences a clinical-stage biotechnology company and has served in those roles since 2013.We are happy to have Dr. Bolno join our Board at this critical moment while we transition toward a f
Wed Sep 24, 2025
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 . GeneDx Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.
Thu Sep 18, 2025
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences. CAMBRIDGE Mass. Sept. 18 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE) a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health today announced that it will host a virtual Research Day on Wednesday October 29 2025 at 10:00 a.m. ET. In addition members of Waves management team are scheduled to parti
Thu Sep 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings